CAPRICOR THERAPEUTICS INC (CAPR) Stock Balance Sheet
NASDAQ:CAPR - Nasdaq - US14070B3096 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 28.79M | 11.29M | 14.69M | 9.60M | 34.89M | |||
| Marketable Securities | 115.98M | 140.23M | 24.79M | 31.82M | N/A | |||
| Receivables | 59.80K | 10.37M | 10.37M | 550.00K | 390.00K | |||
| Other Current Assets | 1.41M | 1.50M | 995.80K | 920.00K | 1.16M | |||
| Total Current Assets | 146.25M | 163.39M | 50.86M | 42.89M | 36.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.26M | 6.87M | 7.61M | 6.94M | 4.62M | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 253.40K | 221.70K | 268.20K | 270.00K | 280.00K | |||
| Total Non-Current Assets | 7.51M | 7.10M | 7.88M | 7.20M | 4.89M | |||
| TOTAL ASSETS | 153.77M | 170.48M | 58.73M | 50.09M | 41.33M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 5.08M | 834.80K | 749.10K | 680.00K | 420.00K | |||
| Accounts Payable | 5.25M | 8.19M | 6.25M | 4.92M | 3.72M | |||
| Other Current Liabilities | 12.00M | 12.00M | 24.27M | 17.98M | N/A | |||
| Total Current Liabilities | 22.34M | 21.03M | 31.27M | 23.59M | 4.13M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.38M | 3.38M | 3.38M | 3.38M | 3.38M | |||
| Other Non-Current Liabilities | 407.40K | 616.30K | 1.49M | 11.35M | 2.45M | |||
| Total Non-Current Liabilities | 3.78M | 3.99M | 4.86M | 14.72M | 5.83M | |||
| TOTAL LIABILITIES | 26.12M | 25.02M | 36.13M | 38.31M | 9.96M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -224.23M | -199.83M | -159.37M | -137.08M | -108.06M | |||
| Additional Paid In Capital | 350.01M | 344.22M | 181.70M | 148.74M | 139.40M | |||
| Common Shares | 45.70K | 45.60K | 31.20K | 30.00K | 20.00K | |||
| Other Shareholders' Equity | 1.81M | 1.03M | 235.80K | 110.00K | N/A | |||
| Shares Outstanding | 45.68M | 45.58M | 31.15M | 25.24M | 24.19M | |||
| Tangible Book Value per Share | 2.79 | 3.19 | 0.73 | 0.47 | 1.30 | |||
| Total Shareholders' Equity | 127.65M | 145.46M | 22.60M | 11.79M | 31.37M | |||
| TOTAL LIABILITIES AND EQUITY | 153.77M | 170.48M | 58.73M | 50.09M | 41.33M | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.02 | 0.15 | 0.29 | 0.11 | |||
| Current Ratio | 6.55 | 7.77 | 1.63 | 1.82 | 8.82 | |||
| Return On Assets (ROA) | -35.81% | -23.74% | -37.95% | -57.94% | -48.44% | |||
| Return On Equity (ROE) | -43.14% | -27.82% | -98.61% | -246.14% | -63.82% | |||
All data in USD , ROIC based on taxRate of 0.21